IL103758A - Tumor specific monoclonal antibodies - Google Patents

Tumor specific monoclonal antibodies

Info

Publication number
IL103758A
IL103758A IL10375892A IL10375892A IL103758A IL 103758 A IL103758 A IL 103758A IL 10375892 A IL10375892 A IL 10375892A IL 10375892 A IL10375892 A IL 10375892A IL 103758 A IL103758 A IL 103758A
Authority
IL
Israel
Prior art keywords
cells
tumor
human
monoclonal antibodies
amino acid
Prior art date
Application number
IL10375892A
Other languages
English (en)
Other versions
IL103758A0 (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IL103758A0 publication Critical patent/IL103758A0/xx
Publication of IL103758A publication Critical patent/IL103758A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL10375892A 1991-12-13 1992-11-16 Tumor specific monoclonal antibodies IL103758A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80730091A 1991-12-13 1991-12-13

Publications (2)

Publication Number Publication Date
IL103758A0 IL103758A0 (en) 1993-04-04
IL103758A true IL103758A (en) 1998-07-15

Family

ID=25196057

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10375892A IL103758A (en) 1991-12-13 1992-11-16 Tumor specific monoclonal antibodies

Country Status (12)

Country Link
EP (1) EP0546634A3 (enExample)
JP (1) JP3539985B2 (enExample)
KR (1) KR930013103A (enExample)
AU (1) AU651261B2 (enExample)
CA (1) CA2083542A1 (enExample)
FI (1) FI925638L (enExample)
HU (1) HU218081B (enExample)
IL (1) IL103758A (enExample)
NO (1) NO924803L (enExample)
NZ (1) NZ245443A (enExample)
TW (1) TW271450B (enExample)
ZA (1) ZA928880B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0108923B8 (pt) 2000-03-03 2021-05-25 Cambridge Antibody Tech Limited elemento de ligação específico, ácido nucleico isolado, célula hospedeira, métodos para produzir um elemento de ligação específico ou domínio vh ou vl de anticorpo, e, para obter um elemento de ligação específico que liga eotaxina
US6946546B2 (en) 2000-03-06 2005-09-20 Cambridge Antibody Technology Limited Human antibodies against eotaxin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4322879A (en) * 1978-01-11 1979-07-19 Massachusetts General Hospital, The Producing antibodies
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
US4997762A (en) 1984-01-31 1991-03-05 Akzo N.V. Tumor associated monocoloal antibodies derived from human B-cell line
WO1989000050A1 (en) * 1987-07-02 1989-01-12 Akzo N.V. Antigen recognized by mca 16-88

Also Published As

Publication number Publication date
IL103758A0 (en) 1993-04-04
FI925638A0 (fi) 1992-12-11
NZ245443A (en) 1995-12-21
NO924803L (no) 1993-06-14
TW271450B (enExample) 1996-03-01
HU9203932D0 (en) 1993-04-28
JPH05317042A (ja) 1993-12-03
FI925638A7 (fi) 1993-06-14
CA2083542A1 (en) 1993-06-14
AU651261B2 (en) 1994-07-14
NO924803D0 (no) 1992-12-11
KR930013103A (ko) 1993-07-21
FI925638L (fi) 1993-06-14
EP0546634A2 (en) 1993-06-16
AU3008892A (en) 1993-06-17
HUT65480A (en) 1994-06-28
JP3539985B2 (ja) 2004-07-07
EP0546634A3 (en) 1994-09-21
ZA928880B (en) 1993-08-12
HU218081B (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
US4828991A (en) Tumor specific monoclonal antibodies
EP0151030B1 (en) Tumor specific monoclonal antibodies
US4997762A (en) Tumor associated monocoloal antibodies derived from human B-cell line
JP2002507398A (ja) ヒト・モノクローナル抗体およびそのための使用の開発
US8394368B2 (en) Method for producing a composition for promoting survival of transplanted hematopoietic stem cell
US5106738A (en) Tumor specific monoclonal antibodies
US5474755A (en) Tumor associated monoclonal antibodies
AU651261B2 (en) Tumor associated monoclonal antibody 88BV59
US5495002A (en) Tumor associated monoclonal antibody 123AV16
US5180814A (en) Tumor specific monoclonal antibodies
US5348880A (en) Tumor associated monoclonal antibody 81AV/78
EP0584267B1 (en) Tumor associated monoclonal antibody 81av78
AU698184B2 (en) Monoclonal antibody 88BV59, subclones and method of making

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired